Croup 

  • Author: Germaine L Defendi, MD, MS, FAAP; Chief Editor: Russell W Steele, MD   more...
 
Updated: Oct 5, 2011
 

Background

Croup is a common, primarily pediatric viral respiratory tract illness. As its alternative names, laryngotracheitis and laryngotracheobronchitis, indicate, croup generally affects the larynx and trachea, although it may also extend to the bronchi. It is the most common etiology for hoarseness, cough, and onset of acute stridor in febrile children. The vast majority of children with croup recover without consequences or sequelae; however, it may be life-threatening (see the image below). (See Etiology, Epidemiology, Prognosis, Clinical, and Treatment.)

Child with croup. Note the steeple or pencil sign Child with croup. Note the steeple or pencil sign of the proximal trachea evident on this anteroposterior film. Courtesy of Dr. Kelly Marshall, CHOA at Scottish Rite.

Croup manifests as hoarseness, a seal-like barking cough, and a variable degree of respiratory distress. However, morbidity is secondary to narrowing of the larynx and trachea below the level of the glottis (subglottic region), causing the hallmark marked inspiratory stridor. (See Prognosis, Clinical, and Workup.)

Stridor

Stridor[1] is a common symptom in patients with croup. The acute onset of this abnormal sound alarms parents enough to prompt an urgent care or emergency department visit. Stridor is an audible harsh, high-pitched, musical sound produced by turbulent airflow through a partially obstructed upper airway. This partial airway obstruction can be present at the level of the supraglottis, glottis, subglottis, and/or trachea. During inspiration, areas of the airway that are easily collapsible (eg, supraglottic region) are suctioned closed because of negative intraluminal pressure generated during inspiration. These same areas are forced open during expiration.

Depending on timing within the respiratory cycle, stridor can be heard on inspiration, expiration, or in both (biphasic; inspiratory and expiratory). Inspiratory stridor suggests a laryngeal obstruction, whereas expiratory stridor suggests tracheobronchial obstruction. Biphasic stridor indicates either a subglottic or glottic anomaly. An acute onset of marked inspiratory stridor is one of the hallmarks of croup; however, there also may be less audible expiratory stridor. (See Clinical.)

Young children who present with stridor require a meticulous evaluation to determine the etiology and, most importantly, to exclude rare life-threatening causes. Although croup is usually a mild, self-limited disease, upper airway obstruction may result in respiratory distress and even death. (See Prognosis, Clinical, and Workup.)

Patient education

For patient education information, see the Lung Disease and Respiratory Health Center, as well as Croup.

Next

Etiology

Viruses causing acute infectious croup are spread through either direct inhalation from a cough and/or sneeze or by contamination of hands with then touching the mucosa of the eyes, nose, and/or mouth. The most common viral etiologies are parainfluenza viruses. The primary ports of entry are the nose and nasopharynx. The infection spreads and eventually involves the larynx and trachea. Although the lower respiratory tract may also be affected, some authors consider laryngotracheobronchitis a separate entity, with bacterial superinfection as the potential cause.

Inflammation and edema of the subglottic larynx and trachea, especially near the cricoid cartilage, are most clinically significant. Histologically, the involved area is edematous, with cellular infiltration located in the lamina propria, submucosa, and adventitia. The infiltrate contains lymphocytes, histiocytes, plasma cells, and neutrophils. Parainfluenzae virus activates chloride secretion and inhibits sodium absorption across the tracheal epithelium, contributing to airway edema. This is the narrowest part of the pediatric airway; accordingly, swelling can significantly reduce the diameter, limiting airflow. This narrowing results in the seal-like barky cough, turbulent airflow and stridor, and chest retractions.

Endothelial damage and loss of ciliary function occurs. A fibrinous exudate partially occludes the lumen of the trachea. Decreased mobility of the vocal cords due to edema leads to the associated hoarseness.

In severe disease, fibrinous exudates and pseudomembranes may develop, causing even greater airway obstruction. Hypoxemia may occur from progressive luminal narrowing and impaired alveolar ventilation and ventilation-perfusion mismatch.

Spasmodic croup (laryngismus stridulus) may be a noninfectious variant of the disorder, with a clinical presentation similar to that of the acute disease but with less coryza. This type of croup always occurs at night and has the hallmark of reoccurring in children; hence it has also been called “frequently recurrent croup.” In spasmodic croup, subglottic edema occurs without the inflammation typical in viral disease. Although viral illnesses may trigger this variant, the reaction may be allergic rather than a direct result of infection.

Causes

The parainfluenza viruses (types 1, 2, 3) are responsible for as many as 80% of croup cases, with parainfluenza type 1 accounting for about 66% of cases, as well as for the majority of hospitalizations.

Other infectious causes of croup include:

  • Adenovirus
  • Respiratory syncytial virus (RSV)
  • Enterovirus
  • Coronavirus
  • Rhinovirus
  • Echovirus
  • Reovirus
  • Metapneumovirus[2]
  • Rarer causes - Measles virus, herpes simplex virus, varicella

Influenza A is associated with severe disease; it has been implicated in children with severe respiratory compromise. Mycoplasma pneumoniae has been implicated in a few cases of croup.

Previous
Next

Epidemiology

Croup is the most common pediatric illness that causes acute stridor, accounting for approximately 15% of clinic and emergency department visits for pediatric respiratory tract infections. It is primarily a disease of infants and toddlers, with a peak incidence from age 6 months to 36 months (3 years). In North America, incidence peaks in the second year of life, at 5-6 cases per 100 children. Although the disease is rare after age 6 years, it may be seen as late as ages 12-15 years.

The male-to-female ratio for croup is approximately 1.4:1. The disease is most common in late fall and early winter but may be seen at any time of year. Approximately 5% of children experience more than 1 episode.

Previous
Next

Prognosis

The prognosis for croup is excellent, and recovery is usually complete. The majority of patients are managed successfully as outpatients, without the need for inpatient hospital care. Hospitalization rates vary widely among communities, ranging from 1.5-30% and typically averaging 2-5%. Throughout the 1990s, US hospitalizations averaged approximately 41,000 per year but appear to have subsequently decreased. Fewer than 2% of hospitalized children require intubation. Although exact mortality is unknown, one 10-year study found a mortality rate of less than 0.5% in intubated patients.[3]

Some evidence suggests that hospitalization for croup may be associated with a future development of asthma. In at least 1 study, children hospitalized for croup later demonstrated higher levels of bronchial hyperresponsiveness and an allergic response to skin testing.

Complications

Complications in croup are rare. In most series, less than 5% of children who were diagnosed with croup required hospitalization and less than 2% of those who were hospitalized were intubated. Death occurred in approximately 0.5% of intubated patients.

Bacterial superinfection may result in pneumonia or bacterial tracheitis, a life-threatening infection that can arise after an acute viral respiratory infection.[4, 5, 6, 7] The child usually has a mild to moderate illness for 2-7 days, but then develops severe symptoms. These patients usually have a toxic appearance and do not respond well to nebulized racemic epinephrine.

Treatment in these cases requires close observation, broad-spectrum antibiotics, and, occasionally, endotracheal intubation. The most frequent organism is Staphylococcus aureus, followed by group A streptococcus (Streptococcus pyogenes), Moraxella catarrhalis, Streptococcus pneumoniae, Haemophilus influenzae, and anaerobes.

Pulmonary edema, pneumothorax, lymphadenitis, and otitis media have also been reported in croup. An inability to maintain adequate oral intake and increased insensible fluid losses can lead to dehydration; as such, patients may require intravenous fluid hydration to stabilize their fluid volume.

Previous
 
 
Contributor Information and Disclosures
Author

Germaine L Defendi, MD, MS, FAAP  Associate Clinical Professor, Department of Pediatrics, Olive View-UCLA Medical Center

Germaine L Defendi, MD, MS, FAAP is a member of the following medical societies: American Academy of Pediatrics

Disclosure: Nothing to disclose.

Coauthor(s)

Antonio Muñiz, MD  Professor of Emergency Medicine and Pediatrics, University of Texas Medical School at Houston; Medical Director of the Pediatric Emergency Department, Children's Memorial Hermann Hospital

Antonio Muñiz, MD is a member of the following medical societies: American Academy of Emergency Medicine, American Academy of Pediatrics, American College of Emergency Physicians, American Heart Association, American Medical Association, Society for Academic Emergency Medicine, and Southern Medical Association

Disclosure: Nothing to disclose.

Rona E Molodow, MD, JD  Clinical Professor, Department of Pediatrics, Olive View-UCLA Medical Center

Rona E Molodow, MD, JD is a member of the following medical societies: American Academy of Pediatrics and American Professional Society on the Abuse of Children

Disclosure: Nothing to disclose.

Chief Editor

Russell W Steele, MD  Head, Division of Pediatric Infectious Diseases, Ochsner Children's Health Center; Clinical Professor, Department of Pediatrics, Tulane University School of Medicine

Russell W Steele, MD is a member of the following medical societies: American Academy of Pediatrics, American Association of Immunologists, American Pediatric Society, American Society for Microbiology, Infectious Diseases Society of America, Louisiana State Medical Society, Pediatric Infectious Diseases Society, Society for Pediatric Research, and Southern Medical Association

Disclosure: Nothing to disclose.

Additional Contributors

Joseph Domachowske, MD Professor of Pediatrics, Microbiology and Immunology, Department of Pediatrics, Division of Infectious Diseases, State University of New York Upstate Medical University

Joseph Domachowske, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Pediatrics, American Society for Microbiology, Infectious Diseases Society of America, Pediatric Infectious Diseases Society, and Phi Beta Kappa

Disclosure: Nothing to disclose.

Mary L Windle, PharmD Adjunct Associate Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Nothing to disclose.

References
  1. Benson BE, Baredes S, Schwartz RA. Stridor. Medscape Reference by WebMD [serial online]. January 26, 2010;Accessed October 5, 2011. Available at http://emedicine.medscape.com/article/995267-overview.

  2. Williams JV, Harris PA, Tollefson SJ, Halburnt-Rush LL, Pingsterhaus JM, Edwards KM, et al. Human metapneumovirus and lower respiratory tract disease in otherwise healthy infants and children. N Engl J Med. Jan 29 2004;350(5):443-50. [Medline]. [Full Text].

  3. Segal AO, Crighton EJ, Moineddin R, Mamdani M, Upshur RE. Croup hospitalizations in Ontario: a 14-year time-series analysis. Pediatrics. Jul 2005;116(1):51-5. [Medline].

  4. Bernstein T, Brilli R, Jacobs B. Is bacterial tracheitis changing? A 14-month experience in a pediatric intensive care unit. Clin Infect Dis. Sep 1998;27(3):458-62. [Medline].

  5. Donnelly BW, McMillan JA, Weiner LB. Bacterial tracheitis: report of eight new cases and review. Rev Infect Dis. Sep-Oct 1990;12(5):729-35. [Medline].

  6. Edwards KM, Dundon MC, Altemeier WA. Bacterial tracheitis as a complication of viral croup. Pediatr Infect Dis. Sep-Oct 1983;2(5):390-1. [Medline].

  7. Jones R, Santos JI, Overall JC Jr. Bacterial tracheitis. JAMA. Aug 24-31 1979;242(8):721-6. [Medline].

  8. Johnson D. Croup. Clin Evid (Online). Mar 10 2009;2009:[Medline]. [Full Text].

  9. [Guideline] Alberta Medical Association. Guideline for the diagnosis and management of croup. Alberta Clinical Practice Guidelines 2005 Update. [Full Text].

  10. Kirks DR. The respiratory system. In: Practical Pediatric Imaging: Diagnostic Radiology of Infants and Children. 3rd ed. Philadelphia, Pa: Lippincott-Raven; 1998:651-53.

  11. Bjornson C, Russell KF, Vandermeer B, Durec T, Klassen TP, Johnson DW. Nebulized epinephrine for croup in children. Cochrane Database Syst Rev. Feb 16 2011;CD006619. [Medline].

  12. [Best Evidence] Scolnik D, Coates AL, Stephens D, Da Silva Z, Lavine E, Schuh S. Controlled delivery of high vs low humidity vs mist therapy for croup in emergency departments: a randomized controlled trial. JAMA. Mar 15 2006;295(11):1274-80. [Medline].

  13. Colletti JE. Myth: Cool mist is an effective therapy in the management of croup. CJEM. Sep 2004;6(5):357-8. [Medline].

  14. Humidified air inhalation for treating croup [database online]. Cochrane Database of Systematic Reviews; 2006.

  15. Moore M, Little P. Humidified air inhalation for treating croup: a systematic review and meta-analysis. Fam Pract. Sep 2007;24(4):295-301. [Medline].

  16. Bjornson CL, Klassen TP, Williamson J, Brant R, Mitton C, Plint A, et al. A randomized trial of a single dose of oral dexamethasone for mild croup. N Engl J Med. Sep 23 2004;351(13):1306-13. [Medline].

  17. Cetinkaya F, Tüfekçi BS, Kutluk G. A comparison of nebulized budesonide, and intramuscular, and oral dexamethasone for treatment of croup. Int J Pediatr Otorhinolaryngol. Apr 2004;68(4):453-6. [Medline].

  18. Chub-Uppakarn S, Sangsupawanich P. A randomized comparison of dexamethasone 0.15 mg/kg versus 0.6 mg/kg for the treatment of moderate to severe croup. Int J Pediatr Otorhinolaryngol. Mar 2007;71(3):473-7. [Medline].

  19. Fifoot AA, Ting JY. Comparison between single-dose oral prednisolone and oral dexamethasone in the treatment of croup: a randomized, double-blinded clinical trial. Emerg Med Australas. Feb 2007;19(1):51-8. [Medline].

  20. Russell K, Wiebe N, Saenz A, Ausejo SM, Johnson D, Hartling L, et al. Glucocorticoids for croup. Cochrane Database Syst Rev. 2004;CD001955. [Medline].

  21. Amir L, Hubermann H, Halevi A, Mor M, Mimouni M, Waisman Y. Oral betamethasone versus intramuscular dexamethasone for the treatment of mild to moderate viral croup: a prospective, randomized trial. Pediatr Emerg Care. Aug 2006;22(8):541-4. [Medline].

  22. Sparrow A, Geelhoed G. Prednisolone versus dexamethasone in croup: a randomised equivalence trial. Arch Dis Child. Jul 2006;91(7):580-3. [Medline]. [Full Text].

  23. McGee DL, Wald DA, Hinchliffe S. Helium-oxygen therapy in the emergency department. J Emerg Med. May-Jun 1997;15(3):291-6. [Medline].

  24. Vorwerk C, Coats TJ. Use of helium-oxygen mixtures in the treatment of croup: a systematic review. Emerg Med J. Sep 2008;25(9):547-50. [Medline].

  25. Beckmann KR, Brueggemann WM Jr. Heliox treatment of severe croup. Am J Emerg Med. Oct 2000;18(6):735-6. [Medline].

  26. Terregino CA, Nairn SJ, Chansky ME, Kass JE. The effect of heliox on croup: a pilot study. Acad Emerg Med. Nov 1998;5(11):1130-3. [Medline].

  27. Weber JE, Chudnofsky CR, Younger JG, Larkin GL, Boczar M, Wilkerson MD, et al. A randomized comparison of helium-oxygen mixture (Heliox) and racemic epinephrine for the treatment of moderate to severe croup. Pediatrics. Jun 2001;107(6):E96. [Medline].

  28. [Best Evidence] Vorwerk C, Coats T. Heliox for croup in children. Cochrane Database Syst Rev. Feb 17 2010;CD006822. [Medline].

  29. Dobrovoljac M, Geelhoed GC. 27 years of croup: an update highlighting the effectiveness of 0.15 mg/kg of dexamethasone. Emerg Med Australas. Aug 2009;21(4):309-14. [Medline].

Previous
Next
 
Child with croup. Note the steeple or pencil sign of the proximal trachea evident on this anteroposterior film. Courtesy of Dr. Kelly Marshall, CHOA at Scottish Rite.
Steeple sign on radiograph.
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2012 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.